Neurontin (Gabapentin)

Gabapentin binds to the α2δ subunit of voltage‑gated calcium channels in the central nervous system. This binding limits calcium entry during neuronal firing, which in turn reduces the release of excitatory neurotransmitters. The resulting decrease in neuronal hyperexcitability underlies its anticonvulsant and analgesic effects.

The appropriate dose of Neurontin is individualized by the prescribing clinician based on the specific indication, patient age, renal function, and response to therapy. Dosage adjustments are especially important in patients with impaired kidney function to avoid accumulation.

Neurontin is classified as pregnancy category C, meaning risk cannot be ruled out. It should only be used when the potential benefit justifies the potential risk to the fetus. Limited data are available for breastfeeding, so clinicians should weigh benefits against possible exposure to the infant.

To request Neurontin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with tricyclic antidepressants or serotonin‑norepinephrine reuptake inhibitors, gabapentin offers a different mechanism focused on calcium channel modulation. It is generally well tolerated, but may cause sedation. Choice of therapy depends on patient comorbidities, side‑effect profiles, and individual response.

Neurontin should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight and excessive heat to maintain stability throughout its shelf life.

Neurontin is taken orally, usually as tablets or capsules, with or without food. The exact administration schedule—such as once, twice or three times daily—is determined by the prescriber based on the therapeutic indication and patient factors.

Serious adverse events include severe allergic reactions such as Stevens‑Johnson syndrome, suicidal thoughts or behaviors, and acute respiratory depression, especially when combined with other central nervous system depressants. Prompt medical attention is required if any of these symptoms arise.

Neurontin is contraindicated in patients with known hypersensitivity to gabapentin or any of its excipients. Caution is also advised for individuals with severe renal impairment, uncontrolled depression, or a history of suicidal ideation, as these conditions may increase the risk of adverse outcomes.